Journal list menu
Export Citations
Download PDFs
Introduction
Full Access
full
The new era of Pompe disease: Advances in the detection, understanding of the phenotypic spectrum, pathophysiology, and management†
- Pages: 1-7
- First Published: 17 January 2012
Articles
Full Access
full
Newborn screening for Pompe disease: An update, 2011†
- Pages: 8-12
- First Published: 17 January 2012
Full Access
full
Autophagy and mitochondria in Pompe disease: Nothing is so new as what has long been forgotten†
- Pages: 13-21
- First Published: 17 January 2012
Full Access
full
Cognitive and adaptive functioning of children with infantile Pompe disease treated with enzyme replacement therapy: Long-term follow-up† ‡§
- Pages: 22-29
- First Published: 17 January 2012
Full Access
full
The role of immune tolerance induction in restoration of the efficacy of ERT in Pompe disease†‡§¶
- Pages: 30-39
- First Published: 17 January 2012
Full Access
full
Predicting cross-reactive immunological material (CRIM) status in Pompe disease using GAA mutations: Lessons learned from 10 years of clinical laboratory testing experience†
- Pages: 40-49
- First Published: 17 January 2012
Full Access
full
Assessing disease severity in Pompe disease: The roles of a urinary glucose tetrasaccharide biomarker and imaging techniques†
- Pages: 50-58
- First Published: 17 January 2012
Full Access
full
The genotype–phenotype correlation in Pompe disease†‡
- Pages: 59-68
- First Published: 17 January 2012
Full Access
full
Infantile Pompe disease on ERT—Update on clinical presentation, musculoskeletal management, and exercise considerations†
- Pages: 69-79
- First Published: 17 January 2012
Full Access
full
Toward deconstructing the phenotype of late-onset Pompe disease†‡
- Pages: 80-88
- First Published: 17 January 2012